Miranda Payne

2.3k total citations
50 papers, 1.3k citations indexed

About

Miranda Payne is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Miranda Payne has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 15 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Miranda Payne's work include Cancer Immunotherapy and Biomarkers (20 papers), Cutaneous Melanoma Detection and Management (11 papers) and CAR-T cell therapy research (10 papers). Miranda Payne is often cited by papers focused on Cancer Immunotherapy and Biomarkers (20 papers), Cutaneous Melanoma Detection and Management (11 papers) and CAR-T cell therapy research (10 papers). Miranda Payne collaborates with scholars based in United Kingdom, United States and Denmark. Miranda Payne's co-authors include Mark R. Middleton, Ian D. Hickson, Helen E.J. Tyrrell, Laura Spiers, Nicholas Coupe, Paul Klenerman, Wai Kit Chu, Katsuhiro Hanada, Benjamin P. Fairfax and Sarah Pratap and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

In The Last Decade

Miranda Payne

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miranda Payne United Kingdom 22 823 502 313 148 141 50 1.3k
Kamel Izeradjene United States 13 714 0.9× 724 1.4× 341 1.1× 89 0.6× 122 0.9× 16 1.5k
Laith Dabbagh Canada 15 546 0.7× 549 1.1× 212 0.7× 194 1.3× 111 0.8× 23 1.3k
Baiyong Li China 21 649 0.8× 524 1.0× 691 2.2× 170 1.1× 85 0.6× 66 1.5k
Miranda Buitenhuis Netherlands 19 431 0.5× 506 1.0× 378 1.2× 91 0.6× 91 0.6× 30 1.3k
Mónica Musteanu Spain 14 552 0.7× 415 0.8× 121 0.4× 149 1.0× 119 0.8× 32 972
Sungyoul Hong United States 19 605 0.7× 634 1.3× 684 2.2× 72 0.5× 109 0.8× 35 1.5k
Lerong Li United States 14 827 1.0× 699 1.4× 386 1.2× 215 1.5× 232 1.6× 21 1.4k
Chang-Yao Hsieh Taiwan 10 542 0.7× 588 1.2× 202 0.6× 65 0.4× 126 0.9× 11 1.1k
Beatrice Belmonte Italy 18 322 0.4× 410 0.8× 360 1.2× 167 1.1× 134 1.0× 61 1.1k
Pablo Matar Argentina 19 673 0.8× 469 0.9× 413 1.3× 308 2.1× 48 0.3× 37 1.3k

Countries citing papers authored by Miranda Payne

Since Specialization
Citations

This map shows the geographic impact of Miranda Payne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda Payne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda Payne more than expected).

Fields of papers citing papers by Miranda Payne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda Payne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda Payne. The network helps show where Miranda Payne may publish in the future.

Co-authorship network of co-authors of Miranda Payne

This figure shows the co-authorship network connecting the top 25 collaborators of Miranda Payne. A scholar is included among the top collaborators of Miranda Payne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miranda Payne. Miranda Payne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Weiyu, Chelsea Taylor, Rosalin Cooper, et al.. (2024). Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination. Journal for ImmunoTherapy of Cancer. 12(4). e008151–e008151. 2 indexed citations
2.
3.
4.
Damato, Valentina, Antonio Berretta, Sudarshini Ramanathan, et al.. (2022). Association Between a Distinctive Autoantibody-Associated Brainstem Sensory Syndrome and Immune Checkpoint Inhibitors. JAMA Neurology. 79(9). 949–949. 6 indexed citations
5.
Ye, Weiyu, Anna Olsson‐Brown, Robert Watson, et al.. (2021). Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles. British Journal of Cancer. 124(10). 1661–1669. 33 indexed citations
6.
Cheung, Vincent, Sarah C. Sasson, Mariya Misheva, et al.. (2021). P93 Faecal microbiota transplant for refractory checkpoint inhibitor immunotherapy-related colitis. A89.1–A89. 2 indexed citations
7.
Fairfax, Benjamin P., Chelsea Taylor, Robert Watson, et al.. (2020). Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma. Nature Medicine. 26(2). 193–199. 198 indexed citations
8.
Nenclares, Pablo, Derfel ap Dafydd, Izhar Bagwan, et al.. (2020). Head and neck mucosal melanoma: The United Kingdom national guidelines. European Journal of Cancer. 138. 11–18. 30 indexed citations
9.
Smith, Henry, Jessica Glen, Howard Peach, et al.. (2020). Less is more: A systematic review and meta-analysis of the outcomes of radical versus conservative primary resection in anorectal melanoma. European Journal of Cancer. 135. 113–120. 20 indexed citations
10.
Cheung, Vincent, Tarun Gupta, Weiyu Ye, et al.. (2019). PTU-061 Immunotherapy-related gastritis in a tertiary oncology centre. A147.2–A147. 6 indexed citations
11.
Cheung, Vincent, Tejpal Gupta, Anna Olsson‐Brown, et al.. (2019). P100 Real-world data: the incidence, diagnosis, and management outcomes of patients with immunotherapy-related colitis in two tertiary centres. Journal of Crohn s and Colitis. 13(Supplement_1). S137–S138. 2 indexed citations
12.
Shah, Ketan, et al.. (2018). Complete spontaneous regression of a metastatic melanoma of the mandible: a case report and follow-up recommendations. International Journal of Oral and Maxillofacial Surgery. 47(12). 1519–1522. 3 indexed citations
13.
Fleeman, Nigel, A Bagust, Angela Boland, et al.. (2017). Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 35(10). 1035–1046. 6 indexed citations
14.
Chu, Wai Kit, Miranda Payne, Petra Beli, et al.. (2015). FBH1 influences DNA replication fork stability and homologous recombination through ubiquitylation of RAD51. Nature Communications. 6(1). 5931–5931. 50 indexed citations
15.
Payne, Miranda, Ruth E. Macpherson, Kevin M. Bradley, & A. Bassim Hassan. (2014). Trabectedin in Advanced High-Grade Uterine Leiomyosarcoma: A Case Report Illustrating the Value of<sup>18</sup>FDG-PET-CT in Assessing Treatment Response. Case Reports in Oncology. 7(1). 132–138. 10 indexed citations
16.
Fugger, Kasper, Wai Kit Chu, Peter Haahr, et al.. (2013). FBH1 co-operates with MUS81 in inducing DNA double-strand breaks and cell death following replication stress. Nature Communications. 4(1). 1423–1423. 72 indexed citations
17.
Blagden, Sarah P., R. Molife, Miranda Payne, et al.. (2005). Phase I study of ispinesib (SB-715992) in combination with docetaxel in patients with advanced solid tumors.. Clinical Cancer Research. 11. 1 indexed citations
18.
Payne, Miranda, et al.. (2002). Gardner's syndrome – A case report. BDJ. 193(7). 383–384. 25 indexed citations
19.
Payne, Miranda, et al.. (1997). Giant cell arteritis--a case report. BDJ. 183(7). 260–262. 1 indexed citations
20.
Payne, Miranda, et al.. (1993). Gingival swelling as a manifestation of non-Hodgkin's lymphoma. BDJ. 175(8). 293–294. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kamel Izeradjene Breakdown of academic impact, for papers by Laith Dabbagh Breakdown of academic impact, for papers by Baiyong Li Breakdown of academic impact, for papers by Miranda Buitenhuis Breakdown of academic impact, for papers by Mónica Musteanu Breakdown of academic impact, for papers by Sungyoul Hong Breakdown of academic impact, for papers by Lerong Li Breakdown of academic impact, for papers by Chang-Yao Hsieh Breakdown of academic impact, for papers by Beatrice Belmonte Breakdown of academic impact, for papers by Pablo Matar
Rankless by CCL
2026